134 related articles for article (PubMed ID: 16510740)
1. Serious adverse drug effects--seeing the trees through the forest.
Gurwitz JH
N Engl J Med; 2006 Mar; 354(13):1413-5. PubMed ID: 16510740
[No Abstract] [Full Text] [Related]
2. Gatifloxacin and dysglycemia in older adults.
Ittner KP
N Engl J Med; 2006 Jun; 354(25):2725-6; author reply 2725-6. PubMed ID: 16790711
[No Abstract] [Full Text] [Related]
3. Gatifloxacin and dysglycemia in older adults.
Yadav V; Deopujari K
N Engl J Med; 2006 Jun; 354(25):2725-6; author reply 2725-6. PubMed ID: 16795151
[No Abstract] [Full Text] [Related]
4. Severe dysglycemia with the fluoroquinolones: a class effect?
Aspinall SL; Good CB; Jiang R; McCarren M; Dong D; Cunningham FE
Clin Infect Dis; 2009 Aug; 49(3):402-8. PubMed ID: 19545207
[TBL] [Abstract][Full Text] [Related]
5. Gatifloxacin produces both hypoglycemia and hyperglycemia: a retrospective study.
Haerian H; McHugh P; Brown R; Somes G; Solomon SS
Am J Med Sci; 2008 Feb; 335(2):95-8. PubMed ID: 18277115
[TBL] [Abstract][Full Text] [Related]
6. Risk of severe dysglycemia among diabetic patients receiving levofloxacin, ciprofloxacin, or moxifloxacin in Taiwan.
Chou HW; Wang JL; Chang CH; Lee JJ; Shau WY; Lai MS
Clin Infect Dis; 2013 Oct; 57(7):971-80. PubMed ID: 23948133
[TBL] [Abstract][Full Text] [Related]
7. Outpatient gatifloxacin therapy and dysglycemia in older adults.
Park-Wyllie LY; Juurlink DN; Kopp A; Shah BR; Stukel TA; Stumpo C; Dresser L; Low DE; Mamdani MM
N Engl J Med; 2006 Mar; 354(13):1352-61. PubMed ID: 16510739
[TBL] [Abstract][Full Text] [Related]
8. Hypoglycemia and hyperglycemia associated with gatifloxacin use in elderly patients.
Biggs WS
J Am Board Fam Pract; 2003; 16(5):455-7. PubMed ID: 14645336
[No Abstract] [Full Text] [Related]
9. Hypoglycemia, hyperglycemia, and gatifloxacin.
Khovidhunkit W; Sunthornyothin S
Ann Intern Med; 2004 Dec; 141(12):969. PubMed ID: 15611501
[No Abstract] [Full Text] [Related]
10. Life-threatening hypoglycemia with moxifloxacin in a dialysis patient.
Kapoor R; Blum D; Batra A; Varma N; Lakshmi K; Basak P; Jesmajian S
J Clin Pharmacol; 2012 Feb; 52(2):269-71. PubMed ID: 21383336
[No Abstract] [Full Text] [Related]
11. Dysglycaemias and fluoroquinolones.
Lewis RJ; Mohr JF
Drug Saf; 2008; 31(4):283-92. PubMed ID: 18366239
[TBL] [Abstract][Full Text] [Related]
12. Gatifloxacin-associated hypoglycemia.
Ali T; Greenfield RA; Scofield H; Bronze MS
J Okla State Med Assoc; 2007 Nov; 100(11):425-8. PubMed ID: 18183859
[TBL] [Abstract][Full Text] [Related]
13. In brief: More fluoroquinolone warnings.
Med Lett Drugs Ther; 2018 Aug; 60(1553):136. PubMed ID: 30133426
[No Abstract] [Full Text] [Related]
14. Stronger warning for antibiotic Tequin.
FDA Consum; 2006; 40(3):4. PubMed ID: 16906655
[No Abstract] [Full Text] [Related]
15. Gatifloxacin therapy associated with hypoglycemia.
Greenberg AL; Decerbo M; Fan J
Clin Infect Dis; 2005 Apr; 40(8):1210-1. PubMed ID: 15791528
[No Abstract] [Full Text] [Related]
16. Fluoroquinolone-associated dysglycemias: a tale of two toxicities.
Owens RC
Pharmacotherapy; 2005 Oct; 25(10):1291-5. PubMed ID: 16185171
[No Abstract] [Full Text] [Related]
17. People with diabetes should avoid antibiotic gatifloxacin.
Kendall C; Wooltorton E
CMAJ; 2006 Apr; 174(8):1089-90. PubMed ID: 16554496
[No Abstract] [Full Text] [Related]
18. Gatifloxacin-induced hyperglycemia.
Bhatia V; Bhatia R; Dhindsa S
Endocr Pract; 2004; 10(1):86. PubMed ID: 15251629
[No Abstract] [Full Text] [Related]
19. Glucose homeostasis abnormalities and gatifloxacin.
Tailor SA; Simor AE; Cornish W; Phillips EJ; Knowles S; Rachlis A
Clin Infect Dis; 2006 Mar; 42(6):895. PubMed ID: 16477578
[No Abstract] [Full Text] [Related]
20. [Hypo or hyperglycemia associated with fluoroquinolone use].
Granados J; Ceballos M; Amariles P
Rev Med Chil; 2018 May; 146(5):618-626. PubMed ID: 30148925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
